Stoke Therapeutics, Inc. (STOK) — Analyst estimates
Consensus analyst estimates for Stoke Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 6.42M | -0.86 | 4 |
| 2027 | 5.50M | -0.81 | 2 |
| 2028 | 124.54M | -1.95 | 7 |
| 2029 | 341.24M | 0.32 | 2 |
| 2030 | 558.31M | 1.82 | 5 |
Consensus analyst estimates by fiscal year.